Annual Accounts Receivable
$81.50 K
+$67.90 K+499.26%
December 31, 2022
Summary
- As of February 10, 2025, PHXM annual accounts receivable is $81.50 thousand, with the most recent change of +$67.90 thousand (+499.26%) on December 31, 2022.
- During the last 3 years, PHXM annual accounts receivable has risen by +$41.20 thousand (+102.23%).
Performance
PHXM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2023
Summary
- PHXM quarterly accounts receivable is not available.
Performance
PHXM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PHXM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +499.3% | - |
| 3 y3 years | +102.2% | - |
| 5 y5 years | -10.6% | - |
PHXM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -83.3% | ||
| 5 y | 5-year | at high | -94.0% | ||
| alltime | all time | -82.4% | -100.0% |
PHAXIAM Therapeutics SA Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $266.30 K(+226.7%) |
| Dec 2022 | $81.50 K(+499.3%) | $81.50 K(-74.5%) |
| Jun 2022 | - | $319.60 K(+2250.0%) |
| Dec 2021 | $13.60 K(+177.6%) | $13.60 K(-18.6%) |
| Jun 2021 | - | $16.70 K(+240.8%) |
| Dec 2020 | $4900.00(-87.8%) | $4900.00(+122.7%) |
| Jun 2020 | - | $2200.00(-94.5%) |
| Dec 2019 | - | $40.30 K(-36.5%) |
| Dec 2019 | $40.30 K(+17.5%) | - |
| Sep 2019 | - | $63.50 K(-93.9%) |
| Jun 2019 | - | $1.04 M(+2939.7%) |
| Dec 2018 | - | $34.30 K |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $34.30 K(-62.4%) | - |
| Dec 2017 | $91.20 K(-60.4%) | $91.20 K(-76.3%) |
| Jun 2017 | - | $384.40 K(+66.8%) |
| Dec 2016 | $230.50 K(-50.3%) | $230.50 K(-57.6%) |
| Jun 2016 | - | $543.90 K(+17.3%) |
| Dec 2015 | $463.60 K(+263.0%) | $463.60 K(+55.0%) |
| Jun 2015 | - | $299.10 K(+134.2%) |
| Dec 2014 | $127.70 K(+6.1%) | $127.70 K(-12.4%) |
| Jun 2014 | - | $145.70 K(+21.0%) |
| Dec 2013 | $120.40 K(>+9900.0%) | $120.40 K(-61.1%) |
| Jun 2013 | - | $309.40 K(>+9900.0%) |
| Dec 2012 | $0.00 | $0.00 |
FAQ
- What is PHAXIAM Therapeutics SA annual accounts receivable?
- What is the all time high annual accounts receivable for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual accounts receivable year-on-year change?
- What is the all time high quarterly accounts receivable for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual accounts receivable?
The current annual accounts receivable of PHXM is $81.50 K
What is the all time high annual accounts receivable for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual accounts receivable is $463.60 K
What is PHAXIAM Therapeutics SA annual accounts receivable year-on-year change?
Over the past year, PHXM annual accounts receivable has changed by +$67.90 K (+499.26%)
What is the all time high quarterly accounts receivable for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly accounts receivable is $1.04 M